Characteristics of United States Food and Drug Administration Drug Recalls Involving Opioid Medications, 2002–2025
Opioid recalls reflect manufacturing or quality assurance problems that may undermine product reliability. More complete recall reporting, including quantitative data, would support efforts to reduce risks associated with pharmaceutical quality failures.
Authors
- Gabriel P. A. Costa (ORCID: https://orcid.org/0009-0007-8702-5436)
- João P. De Aquino (ORCID: https://orcid.org/0000-0001-7357-8215)
- Julio C Nunes
Institutions
- Yale University (US)
- VA Connecticut Healthcare System (US)
- Connecticut Mental Health Center (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1002/pds.70341
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00